Launch Stocks. At least [*****] prior to an anticipated Regulatory Approval in a Major Market Country, the Parties shall discuss and agree upon the manufacture and purchase of specific quantities of Launch Stocks for launch of the Product in the applicable Major Market Country. Launch Stocks shall be ordered not later than [*****] from receipt by Licensee of an approval letter from a Regulatory Authority in respect of an NDA in a Major Market Country.
Appears in 3 contracts
Sources: Supply Agreement, Supply Agreement (Acorda Therapeutics Inc), Supply Agreement (Acorda Therapeutics Inc)